Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$25.26 - $29.6 $89,066 - $104,369
-3,526 Reduced 31.8%
7,562 $211,000
Q1 2024

May 07, 2024

SELL
$25.89 - $29.73 $166,628 - $191,342
-6,436 Reduced 36.73%
11,088 $307,000
Q4 2023

Jan 25, 2024

SELL
$26.13 - $33.94 $735,794 - $955,716
-28,159 Reduced 61.64%
17,524 $504,000
Q3 2023

Nov 07, 2023

SELL
$32.09 - $37.51 $1.98 Million - $2.32 Million
-61,849 Reduced 57.52%
45,683 $1.52 Million
Q2 2023

Jul 31, 2023

BUY
$36.12 - $41.79 $237,344 - $274,602
6,571 Added 6.51%
107,532 $3.94 Million
Q1 2023

May 08, 2023

BUY
$39.39 - $51.28 $23,279 - $30,306
591 Added 0.59%
100,961 $4.12 Million
Q4 2022

Jan 30, 2023

SELL
$41.75 - $54.5 $725,531 - $947,101
-17,378 Reduced 14.76%
100,370 $5.14 Million
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $44,241 - $54,007
1,011 Added 0.87%
117,748 $5.14 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $1.3 Million - $1.54 Million
27,903 Added 31.41%
116,737 $6.07 Million
Q1 2022

May 06, 2022

BUY
$45.75 - $56.69 $2.05 Million - $2.54 Million
44,841 Added 101.93%
88,834 $1.34 Million
Q4 2021

Jan 28, 2022

BUY
$41.32 - $61.25 $1.23 Million - $1.82 Million
29,709 Added 207.99%
43,993 $2.6 Million
Q3 2021

Nov 08, 2021

BUY
$39.25 - $50.42 $560,647 - $720,199
14,284 New
14,284 $614,000
Q4 2020

Jan 14, 2021

SELL
$33.47 - $42.56 $270,939 - $344,523
-8,095 Closed
0 $0
Q3 2020

Oct 26, 2020

SELL
$31.75 - $37.25 $35,560 - $41,720
-1,120 Reduced 12.15%
8,095 $297,000
Q2 2020

Aug 12, 2020

BUY
$30.12 - $36.54 $61,384 - $74,468
2,038 Added 28.4%
9,215 $301,000
Q1 2020

May 12, 2020

BUY
$27.03 - $38.62 $33,652 - $48,081
1,245 Added 20.99%
7,177 $234,000
Q4 2019

Feb 13, 2020

BUY
$32.92 - $37.36 $195,281 - $221,619
5,932 New
5,932 $232,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Americana Partners, LLC Portfolio

Follow Americana Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Americana Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Americana Partners, LLC with notifications on news.